Pinsent Masons advises Best of the Best PLC tender offer

07 Nov 2011 | 11:15 am |

Pinsent Masons is advising AIM listed Best of the Best PLC in relation to a proposed tender offer by Charles Stanley. Best of the Best is an online and airport supercar competition provider and is located at airports and other locations across the UK.

A circular setting out details of the tender offer was despatched to shareholders on 4th November 2011.

The Pinsent Masons team advising on the deal is led by Corporate Partner Paul Amiss assisted by Jessica Zikman and Conor Brindley.

Latest press releases

Show me all press releases

Pinsent Masons advises Simpson Malt Limited on £90m refinancing deal

Multinational law firm Pinsent Masons has advised Simpson Malt Limited on a £90m asset based lending (ABL) facility with PNC Business Credit.

Pinsent Masons wins 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards

Pinsent Masons was named 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards, which was held virtually on 27 November 2020.

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts